Tenaya Therapeutics, Inc.
TNYA • NASDAQ
Tenaya Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Faraz Ali, with a market cap of $144.3M.
CEOFaraz Ali
Next Earnings
Upcoming earnings announcement for Tenaya Therapeutics, Inc.
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.09
Revenue Estimate
$8.5M
Earnings History
Past 12 earnings reports for Tenaya Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | Q4 2025 | -$0.12Est: -$0.12 | 0.0% | - | — | — |
| Nov 10, 2025 | Q3 2025 | -$0.12Est: -$0.15 | +20.0% | - | — |  10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.14Est: -$0.19 | +26.3% | - | — | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.24Est: -$0.20 | -20.0% | - | — | 10-Q |
| Mar 10, 2025 | Q4 2024 | -$0.28Est: -$0.31 | +9.7% | -Est: $1.0M | -100.0% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.30Est: -$0.36 | +16.7% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.34Est: -$0.39 | +12.8% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.40Est: -$0.42 | +4.8% | - | — | 10-Q |
| Mar 18, 2024 | Q4 2023 | -$0.40Est: -$0.44 | +9.1% | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.39Est: -$0.47 | +17.0% | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$0.45Est: -$0.50 | +10.0% | - | — | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.43Est: -$0.56 | +23.2% | - | — | 10-Q |